Contact: Christen Carter
Medical College of Georgia at Georgia Regents University
Caption: Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial, led by GHSU Cancer Center Director Samir N. Khleif, that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Credit: Phil Jones, Georgia Health Sciences University Photographer
Usage Restrictions: None
Related news release: Clinical trial at GHSU Cancer Center targets advanced prostate cancer